Towards the Future of Biopharma: Insights into Oligonucleotide Therapeutics

Dive into the world of biopharma analysis with us as we cover the essential aspects of oligonucleotides, a group of rapidly advancing drugs that offers promising treatments and holds great potential for personalized medicines.

Dive into the world of biopharma analysis with us as we cover the essential aspects of oligonucleotides, a group of rapidly advancing drugs that offers promising treatments and holds great potential for personalized medicines.

We will showcase state-of-the-art solutions that support the entire workflow employed by Contract Drug Manufacturing Organizations (CDMOs), from R&D to validation and manufacturing. Get valuable insights into biopharmaceutical drug development and delve into the capabilities of our solutions, including our Nexera XS inert system, LCMS-9050 QTOF, and the latest LabSolutions Insight Biologics software.

Let’s work towards shaping the future of medicine together. Register now to secure your seat.

Learning Objectives:

• Introduction to the crucial aspects of oligonucleotides as therapeutics
• Understand the increasingly important role of LCMS in biopharma for manufacturing, QC, and confirmation
• Explore Shimadzu’s latest hardware and software solutions